Hector G. Cantua, Mba Email & Phone Number

United States

As principal field clinical engineer at Saluda, I provide strategic leadership and mentorship to elevate the performance and efficiency of the Field Clinical Engineer (FCE) team, focusing on delivering advanced clinical support and technical expertise for cutting-edge medical therapies, particularly in the areas of neurostimulation and closed-loop spinal cord stimulation (SCS). My role encompasses overseeing clinical research initiatives, educational programs, team training, and development, as well as sales enablement processes. • Achieved significant cultural transformation and stability in a dynamic role by implementing the mentorship FCE huddle, designed to foster mentorship, enhance team cohesion, and support professional growth, resulting in a healthier and more stable work environment. • Pioneered the Looped In Calls program, an ongoing, monthly series elevating the US fields overall clinical acumen, achieving 64% annual attendance in FY 2024 as an optional learning tool. • Facilitated a monthly EU/US advanced programming call to ensure global programming cohesion and alignment between the geographies.• Directed a global training initiative to reduce neurostimulator waste, achieving a global completion rate of 100% and significantly lowering scrapped units from ~20 annually to ~2 per year in the US. • Served as a regional lead for Project Elevate, identifying and providing additional resources to elevate clinical acumen of local field teams.• Drove greater patient outcomes by advancing the closed-loop therapy, ensuring team’s thorough understanding of therapies and techniques by conducting clinical research for clinical publications to include the ECAP study, the Rosella APM study, and the Neural Panel study; developed and facilitated multiple levels of new hire training and finals. • Leveraged KOL relationships to assist the local sales team in the conversion of $100K of revenue over the last quarter; on target for an additional $500K per year.

Glen Allen, Virginia, United States

As the FCE leader of clinical research studies, I led the Options, Vectors, and Vanta LE studies, overseeing the design, development, and execution of these research initiatives. My role included consulting on closed-loop studies to enhance commercial workflows, ensuring that research outcomes were seamlessly integrated into practical applications. I coordinated efforts across various departments, including Upstream Marketing, Downstream Marketing, Research and Technology, Commercial Sales, Sales Training and Education, and Business Development. By collaborating with these teams, I provided strategic input to support the ongoing evolution of the SCS therapy and to refine the global business strategy. My leadership ensured that our research initiatives aligned with commercial goals and contributed to the growth and success of our therapies in the marketplace. • Spearheaded team growth, expanding the FCE team from 1 to 12 members, fostering a high-integrity, high-touchpoint organization renowned for strategic site development and clinical research excellence.• Pioneered the design and development of studies and commercial workflows, contributing to closed loop preclinical development and IDE clinical study design.• Successfully pivoted a 600+ in-person launch into a virtual launch to the US and OUS geographies for Differential Target Multiplex (DTM) SCS therapy resulting in achievement of Medtronic Star of Excellence Finalist, one of the company’s most prestigious honors in quality and innovation.

Glen Allen, Virginia, United States

As principal field clinical engineer, I led the design, development, and execution of clinical studies, managing the entire process from site identification through to execution. This involved selecting appropriate research sites, coordinating with study teams, and ensuring that all phases of the clinical trials were conducted efficiently and in compliance with regulatory standards.• Successfully managed clinical research functions, including 67% of all patients and 80% of all sites, achieving exceptional outcomes by strategically identifying research sites within close geographic proximity, optimizing resource allocation, and maximizing study site coverage efficiencies.• Led the global launch of the $111M DTM, a novel SCS waveform integrated from the newly acquired American firm Stimgenics.

Glen Allen, Virginia, United States

As senior field clinical engineer, I executed robust clinical research across the US, adeptly navigating a large corporate matrix and leveraging cross-functional networks to achieve both research and business goals. I developed strong relationships with marketing, engineering, and field teams to ensure seamless resource integration and effective information flow. This collaboration facilitated comprehensive site coverage, optimized marketing efforts, and addressed customer feedback efficiently, ultimately supporting the successful execution of clinical research initiatives and advancing our strategic objectives.• Promoted from Neuromodulation - Pain Clinical Specialist to Senior Field Clinical Engineer in 2013.

Master Of Business Administration - Mba, Business Administration And Management, General, 4.00 - Summa Cum Laude

Activities and Societies: The Honor Society of Phi Kappa Phi

Bachelor Of Science (Bs), Physiological Sciences, Minor In Chemistry

Activities and Societies: McNair Scholar, Minority Medical Education Program (MMEP), Triathlon Team, Cycling Team,